The pituitary tumor transforming gene 1 (PTTG-1): An immunological target for multiple myeloma

被引：0
|
作者：
Maurizio Chiriva-Internati
Raffaele Ferrari
Madhavi Prabhakar
Yuefei Yu
Luigi Baglioni
Jorge Moreno
Nicoletta Gagliano
Nicola Portinaro
Marjorie R Jenkins
Eldo E Frezza
Fred Hardwicke
Nicholas D'Cunha
W Martin Kast
Everardo Cobos
机构：
[1] Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center,Department of Microbiology and Immunology
[2] Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center,Division of Hematology and Oncology
[3] Texas Tech University Health Sciences Center and Southwest Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center,Division of Surgery
[4] University of Milan,Department of Human Morphology
[5] Obstetrics & Gynecology and Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine,Department of Internal Medicine
[6] Texas Tech University Health Sciences Center,Department of Pediatric Orthopedic Surgery
[7] Istituto Clinico Humanitas,Department of Molecular Microbiology & Immunology and Obstetrics & Gynecology, Norris Comprehensive Cancer Center
[8] University of Southern California,undefined
来源：
Journal of Translational Medicine | / 6卷
关键词：
Multiple Myeloma; Fluorescence Activate Cell Sorter; Human Normal Tissue; Multiple Myeloma Patient; Chronic Myelogenous Leukemia Cell Line;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Serum transforming growth factor-β1 is related to the degree of immunoparesis in patients with multiple myeloma
    Kyrtsonis, MC
    Repa, C
    Dedoussis, GVZ
    Mouzaki, A
    Simeonidis, A
    Stamatelou, M
    Maniatis, A
    MEDICAL ONCOLOGY, 1998, 15 (02) : 124 - 128
  • [22] TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma
    Teramachi, Jumpei
    Tenshin, Hirofumi
    Hiasa, Masahiro
    Oda, Asuka
    Bat-Erdene, Ariunzaya
    Harada, Takeshi
    Nakamura, Shingen
    Ashtar, Mohannad
    Shimizu, So
    Iwasa, Masami
    Sogabe, Kimiko
    Oura, Masahiro
    Fujii, Shiro
    Kagawa, Kumiko
    Miki, Hirokazu
    Endo, Itsuro
    Haneji, Tatsuji
    Matsumoto, Toshio
    Abe, Masahiro
    HAEMATOLOGICA, 2021, 106 (05) : 1401 - 1413
  • [23] The histone methyltransferase DOT1L is a potential therapeutic target in multiple myeloma
    Ishiguro, Kazuya
    Sasaki, Hajime
    Wakasugi, Hideki
    Kitajima, Hiroshi
    Niinuma, Takeshi
    Maruyama, Reo
    Kai, Masahiro
    Ikeda, Hiroshi
    Ishida, Tadao
    Sasaki, Yasushi
    Tokino, Takashi
    Nakase, Hiroshi
    Suzuki, Hiromu
    CANCER SCIENCE, 2018, 109 : 690 - 690
  • [24] Proteasome and PARP1 dual-target inhibitor for multiple myeloma: Fluzoparib
    Deng, Kai
    Li, Qiongqiong
    Lu, Lina
    Wang, Luting
    Cheng, Zhiyong
    Wang, Suyun
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2024, 39
  • [25] The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma
    Heimberger, Tanja
    Andrulis, Mindaugas
    Riedel, Simone
    Stuehmer, Thorsten
    Schraud, Heike
    Beilhack, Andreas
    Bumm, Thomas
    Bogen, Bjarne
    Einsele, Hermann
    Bargou, Ralf C.
    Chatterjee, Manik
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (04) : 465 - 476
  • [26] Epigenetic and genetic investigation of SOCS-1 gene in patients with multiple myeloma
    Tuncel, Fatima Ceren
    Serin, Istemi
    Pehlivan, Sacide
    Oyaci, Yasemin
    Pehlivan, Mustafa
    BLOOD RESEARCH, 2022, 57 (04) : 250 - 255
  • [27] Polymorphisms and haplotypes in the multidrug resistance 1 gene (MDR1/ABCB1) and risk of multiple myeloma
    Jamroziak, Krzysztof
    Balcerczak, Ewa
    Calka, Karolina
    Piaskowski, Sylwester
    Urbanska-Rys, Halina
    Salagacka, Aleksandra
    Mirowski, Marek
    Robak, Tadeusz
    LEUKEMIA RESEARCH, 2009, 33 (02) : 332 - 335
  • [28] DLC1 tumor suppressor gene inhibits migration and invasion of multiple myeloma cells through RhoA GTPase pathway
    V Ullmannova-Benson
    M Guan
    X Zhou
    V Tripathi
    X-Y Yang
    D B Zimonjic
    N C Popescu
    Leukemia, 2009, 23 : 383 - 390
  • [29] DLC1 tumor suppressor gene inhibits migration and invasion of multiple myeloma cells through RhoA GTPase pathway
    Ullmannova-Benson, V.
    Guan, M.
    Zhou, X.
    Tripathi, V.
    Yang, X-Y
    Zimonjic, D. B.
    Popescu, N. C.
    LEUKEMIA, 2009, 23 (02) : 383 - 390
  • [30] Chromosome 1 abnormalities in multiple myeloma
    Marzin, Y
    Jamet, D
    Douet-Guilbert, N
    Morel, F
    Le Bris, MJ
    Morice, P
    Abgrall, JF
    Berthou, C
    De Braekeleer, M
    ANTICANCER RESEARCH, 2006, 26 (2A) : 953 - 959
12345